Global Viral Clearance and Viral Testing Services Market Size, Share & Trends Analysis Report By End-user, By Region, and Segment Forecasts, 2023 - 2030
  • Published Date: Nov, 2023
  • |
  • Pages: 200
  • |
  • Industry:
  • |
  • Format: PDF
  • |
  • Share:

  • Report Summary
  • Table of Contents
  • Segmentation
  • Methodology
  • Download Sample

Viral clearance refers to the process of removing or inactivating viruses from biological products, such as vaccines, therapeutic proteins, and blood products, to ensure their safety for use in humans. It involves various steps, including filtration, chromatography, and inactivation methods, to eliminate or reduce viral contaminants. Viral clearance studies are conducted to demonstrate the effectiveness of these processes and provide assurance that the final product is free from harmful viruses.

IMPACT OF COVID 19

Government across the globe have curbed their spend on technology to tackle Covid-19 challenges

Covid-19 pandemic had a positive impact on the market where the demand for viral Clearance increased. Diagnostic laboratories and testing centers experienced a significant increase in testing volumes, requiring them to scale up their capacity to meet the demand.

The long-term impact of COVID-19 on the viral clearance and viral testing services market remains uncertain. The pandemic has underscored the importance of testing and surveillance, which led to sustained investments in viral testing infrastructure, increased awareness, and preparedness for future viral outbreaks.

Market Growth Projections

The viral clearance and viral testing services market is projected to grow at CAGR of 14.2%, with market reaching a projected market size of USD 3,480.8 million by the year 2030. The high demand can be attributed to factors such as growing prevalence of viral diseases, stringent government  regulations, increasing investment in research and development and others.

Driving forces for the market

Increasing prevalence of viral diseases

The rising incidence of viral infections, such as HIV, hepatitis, influenza, and COVID-19, is driving the demand for viral testing services. Effective viral clearance processes are also essential to ensure the safety of biopharmaceuticals and prevent the transmission of viral contaminants.  In addition to this Regulatory agencies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), have established guidelines and regulations for viral clearance and testing. Compliance with these regulations drives the market as manufacturers seek to demonstrate the safety and efficacy of their products.

Restraints

High cost still remains one of the restraints in the market . Viral clearance and testing services can be expensive, especially when advanced technologies and specialized expertise are involved. The high cost can limit the accessibility and affordability of these services, particularly in resource-limited settings or for individuals without adequate healthcare coverage.

Scale of Operation:

The scale of operation segment is sub divided into clinical phase, discovery phase and pre clinical phase. Within these category the clinical phase is expected to have the largest market share, where the segment will contribute approx. 55% to the market in the year 2023 and the category will continue to dominate the market share during the forecast period.

Regional Level Analysis

The report categories the viral Clearance and Viral Testing Services market in four  regions: North America, Europe, Asia Pacific and rest of the world. North American leads in terms of the highest market share where the region alone contributes~40% to the global Viral Clearance and Viral Testing Services market in the year 2023 and the same trend is expected to continue during the forecast period.

Market Players Covered

  • Charles River Laboratories
  • Eurofins Scientific
  • Syngene International
  • WuXi Biologics
  • MilliporeSigma
  • Nelson Labs
  • Vironova
  • Microbac Laboratories
  • Texcell
  • Creative Biolabs
  • JADE Biomedical

Report Components Details
Base Year

2022

Forecast Period

2023 – 2030

Quantitative Units

Revenue in US $ 

Drivers
  • Increasing prevalence of viral diseases 
  • Growing demand for biopharmaceuticals
  • Technological advancements
  • Increased investment in research and development
  • growing awareness and preventive measures 
Challenges
  • High cost
  • Regulatory challenges
  • Lack of skilled professionals
  • Limited awareness and infrastructure in developing regions
Scale of Operation
  • Discovery Phase 
  • Preclinical Phase
  • Clinical Phase
By Method
  • Viral Detection
  • Viral Inactivation
  • Viral Removal
By End User
  • Biotechnology and Pharmaceuticals
  • Academic/Research Institutes
By Region
  • North America
  • Europe
  • Asia Pacific
  • Others
Countries Covered

U.S. and Canada in North America, Germany, Italy, France, UK, Sapim, Rest of Europe in Europe, China, Japan, Australia, India, South Korea, , Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Middle East and Africa (MEA) and Latin America as part of Rest of the World

Table of Contents

1...... Report Overview

2...... Executive Summary

2.2.1               all that is covered in the  report

2.2.2               viral clearance and viral testing services market at a glance

2.2.3               key marketplayers in the marketplace

3...... viral CLEARANCE AND VIRAL TESTING SERVICES market forces

3.1              Introduction

3.2              drivers

3.3              restraints

3.4              opportunities

3.4              challenges

3.5              porters five forces model

3.5.1               threat of new entrants

3.5.2               Threat of substitution

3.5.3               buyers power

3.5.4               suppliers power

3.6              macro economic factors

3.6.1               regulatory

3.6.2               economic

3.6.3               legal

3.6.4               technological

3.6.5               environmental

3.7              covid-19 impact

3.8              recession impact

3.9              russia-ukraine war impact

4...... Viral Clearance and Viral Testing Services, By scale of operation

4.1              Introduction

4.2              discovery phase utility

4.3              clinical phase transportation

4.4              pre clinical phase

5...... Viral Clearance and Viral Testing Services MARKET, By method

5.1              Introduction

5.2              viral detection

5.3              viral inactivation

5.4              viral removal

6...... VIRAL CLEARANCE AND VIRAL TESTING SERVICES MARKET, By end user

6.1              Introduction

6.2              Biotechnology and Pharmaceuticals Companies

6.3              Academic/Research Institutes

7.... north america Viral Clearance and Viral Testing Services MARKET, By segment

7.1              Introduction

7.2             by scale of operation

7.2.1             discovery phase

7.2.2             preclinical phase

7.2.3             clinical phase

7.3             by method

7.3.1             viral detection

7.3.2             viral inactivation

7.3.3             viral removal

7.4             by end user

7.4.1             Biotechnology and Pharmaceuticals Companies

7.4.2              Academic/Research Institutes

7.5              by country

7.5.1             us

7.5.2             canada

8.... europe Viral Clearance and Viral Testing Services MARKET, By segment

8.1              Introduction

8.2             by scale of operation

8.2.1             discovery phase

8.2.2             preclinical phase

8.2.3             clinical phase

8.3             by method

8.3.1             viral detection

8.3.2             viral inactivation

8.3.3             viral removal

8.4             by end user

8.4.1             Biotechnology and Pharmaceuticals Companies

8.4.2              Academic/Research Institutes

8.5              by country

8.5.1             germany

8.5.2             Uk

8.5.3             France

8.5.4             italy

8.5.5             spain

8.5.6             rest of europe

9.... asia pacific Viral Clearance and Viral Testing Services MARKET, By segment

9.1              Introduction

9.2             by scale of operation

9.2.1             discovery phase

9.2.2             preclinical phase

9.2.3             clinical phase

9.3             by method

9.3.1             viral detection

9.3.2             viral inactivation

9.3.3             viral removal

9.4             by end user

9.4.1             Biotechnology and Pharmaceuticals Companies

9.4.2              Academic/Research Institutes

9.5              by country

9.5.1             china

9.5.2             japan

9.5.3             south korea

9.5.4             australia

9.5.5             india

9.5.6             rest of apac

10.. rest of the world Viral Clearance and Viral Testing Services MARKET, By segment

10.1           Introduction

10.2           by scale of operation

10.2.1             discovery phase

10.2.2             preclinical phase

10.2.3             clinical phase

10.3           by method

10.3.1             viral detection

10.3.2             viral inactivation

10.3.3             viral removal

10.4           by end user

10.4.1             Biotechnology and Pharmaceuticals Companies

10.4.2              Academic/Research Institutes

10.5           by country

10.5.1             middle east and africa

10.5.2             latin america

11.... competitive analysis

11.1           Competitive Quadrant – Market Leaders Analysis

11.2           Market Share Analysis – Top 5 Key Vendors

12.... Company Profiles

12.1          Charles River Laboratories

12.2           Eurofins Scientific

12.3           Syngene International

12.4           WuXi Biologicselectric

12.5           MilliporeSigma

12.6           Nelson Labs

12.7           Vironova

12.8           Microbac Laboratories

12.9           Texcell

12.10         Creative Biolabs

12.11         JADE Biomedical

List of TableS

No table of figures entries found.

List of FIGURES

FIGURE 1             VIRAL CLEARANCE AND VIRAL TESTING SERVICES MARKET: RESEARCH DESIGN   9

FIGURE 2             VIRAL CLEARANCE AND VIRAL TESTING SERVICES market snapshot, 2016–2024   14

FIGURE 3             SEGMENT HOLDS LARGEST MARKET SHARE AMONG SERVICE MODELS IN 2019   15

FIGURE 4             STORAGE, BACKUP, AND DISASTER RECOVERY HOLDS LARGEST MARKET SHARE AMONG WORKLOADS IN 2019   15

FIGURE 5             INFRASTRUCTURE AS A SERVICE segment TO GROW AT the HIGHEST RATE during the forecast period   18

FIGURE 6             vertical to grow at the highest rate during the forecast period   21

FIGURE 7             segment to grow at the highest rate during the forecast period   25

FIGURE 8             AWS: COMPANY SNAPSHOT  31

FIGURE 9             AWS: swot analysis  33

Global Viral Clearance and Viral Testing Services Market Segmentation

Viral Clearance and Viral Testing Services by Scale of Operation: Market Size & Forecast 2023-2032

  • Discovery Phase
  • Preclinical Phase
  • Clinical Phase

Viral Clearance and Viral Testing Services by Method: Market Size & Forecast 2023-2032

  • Viral Detection
  • Viral Inactivation
  • Viral Removal

Viral Clearance and Viral Testing Services by End User: Market Size & Forecast 2023-2032

  • Biotechnology and Pharmaceuticals
  • Academic/Research Institutes

Viral Clearance and Viral Testing Services by Geography: Market Size & Forecast 2023-2032

  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Major Players:

  • Charles River Laboratories
  • Eurofins Scientific
  • Syngene International
  • WuXi Biologics
  • MilliporeSigma
  • Nelson Labs
  • Vironova
  • Microbac Laboratories
  • Texcell
  • Creative Biolabs
  • JADE Biomedical

Frequently Asked Questions


Get Your Customized Report